PharmExec Blog
Follow Us
RSS
Bookstore
Category Archives: Manufacturing
Affordable Access to HIV Meds on the Way
UNITAID’s Medicines Patent Pool seeks to bring costly HIV/AIDS treatments and other essential drugs to low-income countries by requiring patent-holders to license their technologies to generics manufacturers. Will pledges of support from the NIH bring some of these patent-holders back to the negotiating table?
A new way for patients to have access to affordable HIV and [...]
Judgment Day for Pfizer Factories
For once, pharma sales reps and R&D guys can breathe a sigh of relief. The latest round of industry layoffs comes from Pfizer, but this time it will affect the manufacturing force, which will be downsized by 6,000 employees by 2015.
In 2006, the company announced plans to save $4 billion to $5 billion, and after [...]
Also posted in Europe, Global, News, Strategy Tagged Cuts, exit strategies, injectables, Ireland, Manufacturing, Pfizer, solid-dose Leave a comment
H1N1 Vaccine Quantities to Fall Short of Predictions
Image by â– Guerry via Flickr
The US may not have as many H1N1 flu vaccines available from the get-go as originally anticipated, CBS News reported on Tuesday.
According to the report, approximately 45 million doses will be available in mid-October—that’s down from the original plan of 120 million doses. The new plan calls for [...]
Posted in Manufacturing Tagged Canada, GlaxoSmithKline, Health, Influenza, Influenza A virus subtype H1N1, Influenza pandemic, Influenza vaccine 2 Comments
WHO Pushes H1N1 Flu to Pandemic State
Image by Quiplash! via Flickr
The Word Health Organization just bumped the H1N1 influenza to pandemic alert phase 6 (the highest alert level), making it the first worldwide pandemic in 41 years.
According to WHO Director-General Margaret Chan, 30,000 cases of the swine flu have been reported in 74 countries, but there is a very good possibility [...]
Also posted in Safety Tagged Centers for Disease Control and Prevention, H1N1, Health, Influenza, Influenza pandemic, Margaret Chan, Oseltamivir, Swine influenza, United States, WHO 1 Comment
Brazil Profile: Latin America's Giant Repositions for Pharma Growth